Laminin-derived multi-domain peptides
US7820172B1 · kind B1 · utility
10Cited by
105References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 1, 2007 |
| Grant date | Oct 26, 2010 |
| Priority date | — |
| Expiry date | Nov 28, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Multi-domain peptides including a heparin-binding peptide sequence covalently linked to a linker sequence, which linker sequence is covalently linked to a trifunctional amino acid residue forming a branch with two arms, with substantially similar (homodimeric) cellular attachment peptide sequences covalently linked, directly or through an intermediate, to each branch arm, where the sequences are cell binding analogs of or derived from laminin or a portion of laminin. Further provided are preparations for medical devices, pharmaceutical compositions and methods of using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.